Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Protein Arginine Methyltransferase 5 Promotes pICln-Dependent Androgen Receptor Transcription in Castration-Resistant Prostate Cancer.
Beketova E, Fang S, Owens JL, Liu S, Chen X, Zhang Q, Asberry AM, Deng X, Malola J, Huang J, Li C, Pili R, Elzey BD, Ratliff TL, Wan J, Hu CD. Beketova E, et al. Among authors: asberry am. Cancer Res. 2020 Nov 15;80(22):4904-4917. doi: 10.1158/0008-5472.CAN-20-1228. Epub 2020 Sep 30. Cancer Res. 2020. PMID: 32999000 Free PMC article.
PRMT5: a putative oncogene and therapeutic target in prostate cancer.
Beketova E, Owens JL, Asberry AM, Hu CD. Beketova E, et al. Among authors: asberry am. Cancer Gene Ther. 2022 Mar;29(3-4):264-276. doi: 10.1038/s41417-021-00327-3. Epub 2021 Apr 14. Cancer Gene Ther. 2022. PMID: 33854218 Free PMC article. Review.
Targeting Protein Arginine Methyltransferase 5 Suppresses Radiation-induced Neuroendocrine Differentiation and Sensitizes Prostate Cancer Cells to Radiation.
Owens JL, Beketova E, Liu S, Shen Q, Pawar JS, Asberry AM, Yang J, Deng X, Elzey BD, Ratliff TL, Cheng L, Choo R, Citrin DE, Polascik TJ, Wang B, Huang J, Li C, Wan J, Hu CD. Owens JL, et al. Among authors: asberry am. Mol Cancer Ther. 2022 Mar 1;21(3):448-459. doi: 10.1158/1535-7163.MCT-21-0103. Mol Cancer Ther. 2022. PMID: 35027481 Free PMC article.